Skip to main content

STIFEL FINANCIAL CORP

Position in NVS — Novartis AG

CIK 720672 ST. LOUIS, MO

Position in NVS

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$48,531,269
+$10,977,966 QoQ
Shares Held
317,717
+16.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 91.39706090640412.ToString("F0")% Shared 0.6294910250317106.ToString("F0")% None 7.973448068564163.ToString("F0")%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $5,042,614,731 across 16 Drug Manufacturers - General names. NVS ranks #10 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $48,531,269 317,717
2025-12-31 $37,553,303 272,382
2025-09-30 $32,925,875 256,752
2025-06-30 $29,447,176 243,345
2025-03-31 $25,847,414 231,857
2024-12-31 $21,544,041 221,396
2024-09-30 $25,192,482 219,027
2024-06-30 $22,435,697 210,743
2024-03-31 $25,088,856 259,370
2023-12-31 $25,273,798 250,310
2023-09-30 $25,636,223 251,681
2023-06-30 $24,845,351 246,213
2023-03-31 $24,523,428 266,559
2022-12-31 $23,553,812 259,632
2022-09-30 $21,645,441 284,771
2022-06-30 $30,592,755 361,916
2022-03-31 $32,841,752 374,265
2021-12-31 $30,237,588 345,691
2021-09-30 $29,692,925 363,083
2021-06-30 $29,869,417 327,372
2021-03-31 $28,559,548 334,108
2020-12-31 $37,618,925 398,379
2020-09-30 $34,613,642 398,041
2020-06-30 $33,869,487 387,789
2020-03-31 $34,410,422 417,349